Author

Ramy Slama

University of Oxford

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Adam C. WilkinsoniD· 1 shared Adam J. MeadiD· 1 shared Bethan PsailaiD· 1 shared Eleni LoukaiD· 1 shared James O. J. DaviesiD· 1 shared Joseph C. HamleyiD· 1 shared Lai Cheng· 1 shared Maria GrecoiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adam C. WilkinsonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genome editing for treatment of JAK2 V617F-driven myeloproliferative neoplasms

Roman M. Doll, Yuqi Shen, Zoë C. Wong, Ramy Slama, Maria Greco, Lai Cheng, Eleni Louka, Weijiao Zhang, Yavor K. Bozhilov, Joseph C. Hamley, Adam C. Wilkinson, Bethan Psaila, Adam J. Mead, James O. J. Davies

This study uses CRISPR-Cas genome editing to selectively inactivate JAK2 V617F mutations in patient cells, showing that heterozygous cells are not oncogene addicted while homozygous cells are eradicated, suggesting genome editing as a potential treatment for MPNs.

bioRxiv · Dec 19, 2025 · PreprintCancer Biology